ArticleTransplant infectious disease : an official journal of the Transplantation Society
Impact of Bebtelovimab Treatment Timing on COVID-19 Outcomes in Ambulatory Solid Organ Transplant Recipients.
Sonsoles Salto-Alejandre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.